Drug Could Derail Synapse Loss in Alzheimer’s
Link http://neurosciencenews.com/synapse-loss-alzheimers-drug-7952/ Summary Synapse loss is a key factor in Alzheimer’s disease that is initiated by amyloid beta peptides.There are two Wnt signalling pathways. The canonical pathway (Wnt–catenin) promotes synapse and neuronal maintenance. The non-canonical pathway (Wnt-PCP) promotes synaptic disassembly and degradation. The pathways work together to provide a balanced maintenance of synapses. In an Alzheimer disease brain the Wnt-PCP pathway is overactive and causes too much synaptic loss. The increased presence of amyloid beta protein triggers the Wnt-PCP synaptic signalling. Researchers investigated whether they could disrupt this pathway to stop the synaptic damage and spreading. The researchers treated mice with a drug called fasudil, which targets a protein called ROCK in the Wnt-PCP signalling pathway. This derais the synaptotoxic cascade of amyloid production. Fasudil shutting off the Wnt-PCP pathway, which protected syn...